[68Ga]Ga-PentixaFor
ICO-2023-17
Phase 1 small_molecule active
Quick answer
[68Ga]Ga-PentixaFor for triple-negative breast cancer is a Phase 1 program (small_molecule) at CERO THERAPEUTICS HOLDINGS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CERO THERAPEUTICS HOLDINGS, INC.
- Indication
- triple-negative breast cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active